New Therapeutic Alternatives for the Management of Dyslipidemia-Reference-Cited by-同舟云学术

New Therapeutic Alternatives for the Management of Dyslipidemia

Published:2013-10-18 Issue:6 Volume:26 Page:528-540
ISSN:0897-1900
Container-title:Journal of Pharmacy Practice
language:en
Short-container-title:Journal of Pharmacy Practice

Author:

Cassagnol Manouchkathe¹,Ezzo Danielle¹,Patel Priti N.¹

Affiliation:

1. St. John’s University, College of Pharmacy and Health Sciences, Department of Clinical Pharmacy Practice, Queens, New York, USA and Long Island Jewish Medical Center, Department of Pharmacy, New Hyde Park, New York, USA

Abstract

Hypercholesterolemia affects over 34 million adults in the United States and is a major cause of coronary heart disease (CHD). Conventional therapies, such as statins, have demonstrated their ability to improve clinical end points and decrease morbidity and mortality in patients with CHD. Lomitapide (Juxtapid®), mipomersen (Kynamro®), and icosapent (Vascepa®) are 3 novel agents approved by the US Food and Drug Administration in the past 2 years, which offer new lipid-lowering treatment options with unique pharmacology.

Publisher

SAGE Publications

Subject

Pharmacology (medical)

Link

http://journals.sagepub.com/doi/pdf/10.1177/0897190013507582

Reference60 articles.

1. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

2. Lifetime risk of developing coronary heart disease

3. Prediction of Coronary Heart Disease Using Risk Factor Categories

4. Is Relationship Between Serum Cholesterol and Risk of Premature Death From Coronary Heart Disease Continuous and Graded?

5. The Lipid Research Clinics Coronary Primary Prevention Trial Results

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frontiers in Lipid Lowering Therapy: To Statins and Beyond;European Journal of Vascular and Endovascular Surgery;2020-12

2. Synergistic effects of pomegranate juice and atorvastatin for improving cerebellar structure and function of breast-feeding rats maternally fed on a high cholesterol diet;Journal of Chemical Neuroanatomy;2020-09

3. Cholesterol overload impairing cerebellar function: The promise of natural products;Nutrition;2015-05